Clinical Development;
Japan/Asia Clinical Research PCU;
Eisai Co.;
Ltd.;
Tokyo;
Japan;
Department of Laboratory Medicine;
Daisan Hospital;
Jikei University School of Medicine;
Tokyo;
Japan;
Japan Regulatory Affairs;
Global Regulatory CFU;
Eisai Co.;
Ltd.;
Tokyo;
Japan;
Sekino Clinical Pharmacology Clinic;
Tokyo;
Japan;
Present address: Pharmaspur;
Inc.;
Tokyo;
Japan;
PPAR; Agonist; Phase; 1; Pharmacokinetics; Healthy; Subjects;